Nicholas Galakatos is Global Head of Life Sciences and Chairman of its Investment Committees. He joined Blackstone in December 2018 when the firm acquired Clarus, where he had been co-Founder and Managing Director since 2005.
He holds a PhD in Organic Chemistry from MIT and an undergraduate degree from Reed College, and completed post-doctoral studies at Harvard Medical School.